Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
Research Watch

Prolonged Stem Cell Lineage Plasticity Underlies Cancer Progression

DOI: 10.1158/2159-8290.CD-RW2017-079 Published June 2017
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major finding: Tumors exhibit persistent stem cell lineage plasticity that occurs transiently in wound repair.

  • Concept: Lineage plasticity maintained by stress-induced transcription factors drives cell proliferation.

  • Impact: Understanding how tumors hijack wound repair programs may lead to discovery of new therapeutic targets.

During wound repair, resident stem cells temporarily favor cell growth and proliferation over differentiation. Tumors exploit this normal process to maintain uncontrolled growth, but the mechanisms underlying the homeostatic shift of stem cells in both wound repair and tumorigenesis are unknown. Using mouse skin as a model, Ge and colleagues utilized the assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) coupled with RNA and chromatin immunoprecipitation sequencing to compare in vivo chromatin states in homeostatic, wound-induced, and squamous cell carcinoma (SCC) stem cells. SCC stem cells had distinct accessibility profiles compared with those of homeostatic hair follicle and epidermal stem cells, and binding motifs for SOX9, normally expressed only in the hair follicle lineage, and KLF5, normally expressed in the epidermis stem cell lineage, were highly accessible in SCC stem cells. SCC stem cells coexpressed both SOX9 and KLF5, and CRISPR/Cas9-mediated deletion of Sox9 or Klf5 in SCC stem cells markedly impaired tumor growth in vivo and proliferation and invasion in vitro, confirming that lineage plasticity contributes to tumor maintenance. Of note, lineage plasticity marked by coexpression of SOX9 and KLF5 also occurred in wound-induced stem cells but was transient and reverted to homeostatic patterns as wounds healed. Accessible chromatin in both wound-induced and SCC stem cells contained unique enhancer elements and was enriched for binding motifs of stress-induced transcription factors such as ETS2, which is known to be required for SCC maintenance and phosphorylated by ERK1/2 during wounding. ETS2 was sufficient to induce lineage plasticity, and sustained ETS2 activity, which occurs in the setting of constitutive MAPK signaling caused by HRAS mutations in SCC, maintained lineage plasticity and commissioning of tumor-specific enhancers. In addition to providing insight into how tumor-associated stem cells lock in what is typically a transient wound-induced stem cell state in the skin, these findings suggest that drivers of sustained lineage plasticity represent potential therapeutic targets.

Ge Y, Gomez NC, Adam RC, Nikolova M, Yang H, Verma A, et al. Stem cell lineage infidelity drives wound repair and cancer. Cell 2017;169:636–50.e14.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2017 American Association for Cancer Research.
View Abstract
PreviousNext
Back to top
Cancer Discovery: 7 (6)
June 2017
Volume 7, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prolonged Stem Cell Lineage Plasticity Underlies Cancer Progression
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prolonged Stem Cell Lineage Plasticity Underlies Cancer Progression
Cancer Discov June 1 2017 (7) (6) 547; DOI: 10.1158/2159-8290.CD-RW2017-079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prolonged Stem Cell Lineage Plasticity Underlies Cancer Progression
Cancer Discov June 1 2017 (7) (6) 547; DOI: 10.1158/2159-8290.CD-RW2017-079
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Mutations in Receptor Tyrosine Kinases Drive Histiocytic Disorders
  • Pembrolizumab Monotherapy Is Active in Metastatic Prostate Cancer
  • MYC Superenhancer–Nuclear Pore Binding Increases MYC-Transcript Export
Show more Research Watch

Stem Cells

  • CXCL12 Has Niche-Specific Roles in Leukemia Stem Cell Function
  • CD10+GPR77+ Cancer-Associated Fibroblasts Promote Chemoresistance
  • LGR5+ Cancer Stem Cells Drive Primary and Metastatic Colorectal Cancer
Show more Stem Cells
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement